LIN28B and neoplasm: First, while our findings suggest a potential link between LIN28B and tumor immunosuppression in EC, it is imperative to validate this mechanistic association through clinical studies correlating LIN28B expression levels with immune checkpoint markers and immune cell infiltration in patient tumor specimens.